CTOs on the Move


 
Headquartered in New York, Dextra is an independent, multi-strategy private equity firm that provides a global investor base access to differentiated middle market investments created through holistic partnerships.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.dextra.com
  • 135 West 50th Street Suite 200
    New York, NY USA 10020
  • Phone: n/a

Executives

Name Title Contact Details

Similar Companies

Conifer

Conifer Group is a leading provider of services to the hedge fund industry that includes global fund accounting and administration, middle office, prime brokerage and execution services.

Capri Capital

Capri Capital is a Chicago, IL-based company in the Financial Services sector.

Greenspring Associates

Greenspring Associates is a Owings Mills, MD-based company in the Financial Services sector.

United Advisors America

United Advisors America (UAA) is an SEC-registered, fee-only investment adviser with its principal place of business in Texas. UAA currently has advisors working with clients across 22 states and is continually expanding. UAA provides a range of wealth and investment management services for individuals and families as well as their businesses. UAA`s advisors, as fiduciaries, are committed to serving in the best interests of their clients in providing investment and retirement solutions that are tailored to their individual financial and lifestyle goals.

Harris and Harris

Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus.  This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach.  We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics.  We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.